PMV Pharmaceuticals Ownership | Who Owns PMV Pharmaceuticals?
PMV Pharmaceuticals Ownership Summary
PMV Pharmaceuticals is owned by 66.68% institutional investors, 2.90% insiders, and 30.42% retail investors. Orbimed advisors is the largest institutional shareholder, holding 11.49% of PMVP shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.94% of its assets in PMV Pharmaceuticals shares.
PMVP Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | PMV Pharmaceuticals | 66.68% | 2.90% | 30.42% |
| Sector | Healthcare Stocks | 492.67% | 11.09% | -403.76% |
| Industry | Biotech Stocks | 295.31% | 11.22% | -206.53% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Orbimed advisors | 5.98M | 11.49% | $8.37M |
| Bml capital management | 5.29M | 10.17% | $7.41M |
| Tang capital management | 4.79M | 9.20% | $6.70M |
| Arrowmark colorado | 3.30M | 6.35% | $4.62M |
| Sio capital management | 2.64M | 5.07% | $3.69M |
| Euclidean capital | 2.63M | 5.05% | $3.68M |
| Vanguard group | 2.16M | 4.16% | $3.03M |
| Acadian asset management | 2.07M | 3.97% | $2.89M |
| Stonepine capital management | 1.37M | 2.63% | $1.92M |
| Blackrock | 1.16M | 2.26% | $1.88M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bml capital management | 5.29M | 6.78% | $7.41M |
| Stonepine capital management | 1.37M | 1.56% | $1.92M |
| Euclidean capital | 2.63M | 1.55% | $3.68M |
| Sio capital management | 2.64M | 0.93% | $3.69M |
| Aldebaran capital | 504.13K | 0.65% | $705.78K |
| Tang capital management | 4.79M | 0.26% | $6.70M |
| Peapod lane capital | 202.78K | 0.25% | $283.91K |
| Orbimed advisors | 5.98M | 0.20% | $8.37M |
| Arrowmark colorado | 3.30M | 0.09% | $4.62M |
| Rangeley capital | 45.50K | 0.06% | $63.70K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tang capital management | 4.79M | 0.26% | 4.79M |
| Marshall wace, llp | 612.63K | 0.00% | 612.63K |
| Stonepine capital management | 1.37M | 1.56% | 524.17K |
| Jane street group | 382.05K | 0.00% | 382.05K |
| Bml capital management | 5.29M | 6.78% | 292.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Pfm health sciences, lp | - | - | -3.30M |
| Alkeon capital management | - | - | -2.34M |
| Blackrock | 1.16M | - | -1.95M |
| Sio capital management | 2.64M | 0.93% | -1.10M |
| Bank of america corp /de/ | 340.39K | - | -1.03M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Tang capital management | 4.79M | 0.26% | 4.79M | $6.70M |
| Marshall wace, llp | 612.63K | 0.00% | 612.63K | $857.68K |
| Jane street group | 382.05K | 0.00% | 382.05K | $534.87M |
| Boothbay fund management | 201.50K | 0.00% | 201.50K | $282.10K |
| Ikarian capital | 97.50K | 0.01% | 97.50K | $136.50K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -8.00 |
| Nisa investment advisors | -105.00 |
| Raymond james financial | -200.00 |
| Avion wealth | -299.00 |
| Capital advisors | -322.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 53 | -5.36% | 34,682,029 | -7.07% | 66 | 1.29% | 19 | 90.00% | 20 | -35.48% |
| Mar 31, 2025 | 6 | -91.67% | 13,804,026 | -64.57% | 26 | 0.47% | 2 | -90.48% | 1 | -96.77% |
| Dec 31, 2024 | 23 | -69.33% | 12,134,994 | -68.90% | 23 | 0.41% | 7 | -75.00% | 8 | -72.41% |
| Sep 30, 2024 | 75 | -19.35% | 39,023,924 | -3.62% | 75 | 1.22% | 29 | -35.56% | 29 | -6.45% |
| Jun 30, 2024 | 93 | -7.00% | 40,490,486 | -5.27% | 78 | 1.14% | 45 | -10.00% | 31 | 19.23% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard US Total Market Shares ETF | 1.52M | 2.94% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.49M | 2.82% | -32.61K |
| Meridian Small Cap Growth Legacy | 1.26M | 2.42% | - |
| ArrowMark Small Cap Gro | 1.26M | 2.42% | - |
| ACAP Strategic A | 1.15M | 2.16% | - |
| SQUAD Aguja Opportunities I | 570.00K | 1.08% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 371.20K | 0.70% | -169.15K |
| BlackRock Advantage Small Cap Core Instl | 280.44K | 0.53% | - |
| Goldman Sachs Small Cp Val Insghts Instl | 249.01K | 0.48% | - |
| Fidelity Extended Market Index | 209.22K | 0.39% | -1.72K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 23, 2025 | ORBIMED ADVISORS LLC | - | Sell | $1.52M |
| Sep 10, 2025 | ORBIMED ADVISORS LLC | - | Sell | $900.00K |
| Jul 01, 2025 | Ticktin Robert | General Counsel & COO | Sell | $24.65K |
| Jul 01, 2025 | Jalota Deepika | Chief Development Officer | Sell | $35.20K |
| Jul 01, 2025 | Carulli Michael | Chief Financial Officer | Sell | $30.08K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 1 |
| 2025 Q3 | - | 5 |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
PMVP Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools